These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 10678366
1. Development of a murine orthotopic model of leukemia: evaluation of TP53 gene therapy efficacy. Bossi G, Scardigli R, Musiani P, Martinelli R, Gentileschi MP, Soddu S, Sacchi A. Cancer Gene Ther; 2000 Jan; 7(1):135-43. PubMed ID: 10678366 [Abstract] [Full Text] [Related]
2. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model. Garcia-Castro J, Rio P, Lillo R, Garcia-Sanchez F, Segovia JC, Bueren JA. Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529 [Abstract] [Full Text] [Related]
3. Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging. Scardigli R, Bossi G, Blandino G, Crescenzi M, Soddu S, Sacchi A. Gene Ther; 1997 Dec; 4(12):1371-8. PubMed ID: 9472561 [Abstract] [Full Text] [Related]
4. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Yu D, Thomas-Tikhonenko A. Oncogene; 2002 Mar 14; 21(12):1922-7. PubMed ID: 11896625 [Abstract] [Full Text] [Related]
5. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells. Gautam SC, Xu YX, Dumaguin M, Janakiraman N, Chapman RA. Cancer Gene Ther; 2000 Jul 14; 7(7):1060-8. PubMed ID: 10917209 [Abstract] [Full Text] [Related]
6. Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ. Wang TJ, Huang MS, Hong CY, Tse V, Silverberg GD, Hsiao M. Biochem Biophys Res Commun; 2001 Sep 14; 287(1):173-80. PubMed ID: 11549271 [Abstract] [Full Text] [Related]
7. IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment. Xu YX, Gao X, Janakiraman N, Chapman RA, Gautam SC. Clin Immunol; 2001 Feb 14; 98(2):180-9. PubMed ID: 11161974 [Abstract] [Full Text] [Related]
8. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice. Zhang XS, Linkhart TA, Chen ST, Peng H, Wergedal JE, Guttierez GG, Sheng MH, Lau KH, Baylink DJ. J Gene Med; 2004 Jan 14; 6(1):4-15. PubMed ID: 14716672 [Abstract] [Full Text] [Related]
9. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors. Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH. Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4511-8. PubMed ID: 17671137 [Abstract] [Full Text] [Related]
10. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene. Murakami T, Tokunaga N, Waku T, Gomi S, Kagawa S, Tanaka N, Fujiwara T. Clin Cancer Res; 2004 Jun 01; 10(11):3871-80. PubMed ID: 15173096 [Abstract] [Full Text] [Related]
11. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer. Sutton MA, Freund CT, Berkman SA, Dang TD, Kattan MW, Wheeler TM, Rowley DR, Lerner SP. Mol Ther; 2000 Sep 01; 2(3):211-7. PubMed ID: 10985951 [Abstract] [Full Text] [Related]
12. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity. Gu J, Andreeff M, Roth JA, Fang B. Gene Ther; 2002 Jan 01; 9(1):30-7. PubMed ID: 11850720 [Abstract] [Full Text] [Related]
13. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells. Timiryasova TM, Chen B, Fodor I. J Gene Med; 2001 Jan 01; 3(5):468-77. PubMed ID: 11601760 [Abstract] [Full Text] [Related]
14. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer]. Yang Q, Yang G, Wei L, Jia F, Wu M, Guo Y. Zhonghua Yi Xue Za Zhi; 2002 Jun 10; 82(11):775-9. PubMed ID: 12126551 [Abstract] [Full Text] [Related]
15. Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes. Zhang Y, Yao W, Zeng Z, Wang X, Sun D, Ka W, Zhou S, He D, Wen Z, Chien S. Microcirculation; 2007 Feb 10; 14(2):155-66. PubMed ID: 17365670 [Abstract] [Full Text] [Related]
16. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer. Lee YK, So IS, Lee SC, Lee JH, Lee CW, Kim WM, Park MK, Lee ST, Park DY, Shin DY, Park CU, Kim YS. J Gene Med; 2005 Feb 10; 7(2):145-57. PubMed ID: 15546163 [Abstract] [Full Text] [Related]
17. Preselective gene therapy for Fabry disease. Qin G, Takenaka T, Telsch K, Kelley L, Howard T, Levade T, Deans R, Howard BH, Malech HL, Brady RO, Medin JA. Proc Natl Acad Sci U S A; 2001 Mar 13; 98(6):3428-33. PubMed ID: 11248095 [Abstract] [Full Text] [Related]
18. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer. Oakley R, Phillips E, Hooper R, Wilson D, Partridge M. Clin Cancer Res; 2002 Jun 13; 8(6):1984-94. PubMed ID: 12060644 [Abstract] [Full Text] [Related]
19. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K. J Gene Med; 2004 Mar 13; 6(3):288-99. PubMed ID: 15026990 [Abstract] [Full Text] [Related]